Possibility of use and effectiveness of oral hypoglyctic drugs in gestational diabetes mellitus: a literature review

Abstract

Gestational diabetes mellitus (GDM) is a serious and frequent concern in pregnancy. Worldwide, the prevalence of GDM ranges from 8 to 20%. In 5% of cases, this pathology is accompanied by complications such as diabetic fetopathy, preeclampsia, neonatal hypoglycemia, and hyperbilirubinemia. Modern national and foreign guidelines for detecting hyperglycemia during pregnancy and diagnosing GDM recommend lifestyle changes and adherence to a carbohydrate-restricted diet as initial therapy. In the absence of positive dynamics against the background of non-drug therapy, the Russian Federation recommends only the use of insulin.

A number of foreign guidelines consider the use of oral hypoglycemic agents (metformin and/or glibenclamide) during pregnancy as an alternative to injectable drugs. In this review, we compared the efficacy and safety of metformin and/or glibenclamide for treating GDM. Metformin and glibenclamide are reliable and safe for correcting the level of blood glucose in pregnant women, but the optimal therapeutic strategy includes their combined use or combined use with insulin.

Keywords

gestational diabetes mellitus / insulin / metformin / glibenclamide / pregnancy

References

[1] Alfadhli EM. Gestational diabetes mellitus. Saudi Med J. 2015;36(4):399–406. doi: 10.15537/smj.2015.4.10307

[2] Alfadhli E.M. Gestational diabetes mellitus // Saudi Med J. 2015. Vol. 36, N 4. P. 399–406. doi: 10.15537/smj.2015.4.10307

[3] Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus Insulin for the Treatment of Gestational Diabetes. N Engl J Med. 2008;358(19):2003–2015. doi: 10.1056/NEJMoa0707193

[4] Rowan J.A., Hague W.M., Gao W., Battin M.R., Moore M.P. Metformin versus Insulin for the Treatment of Gestational Diabetes // N Engl J Med. 2008. Vol. 358, N 19. P. 2003–2015. doi: 10.1056/NEJMoa0707193

[5] Huhtala MS, Tertti K, Juhila J, Sorsa T, Rönnemaa T. Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 ― secondary analysis of a randomized controlled trial. BMC Pregnancy Childbirth. 2020;20(1):401. doi: 10.1186/s12884-020-03077-6

[6] Huhtala M.S., Tertti K., Juhila J., Sorsa T., Rönnemaa T. Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 ― secondary analysis of a randomized controlled trial // BMC Pregnancy Childbirth. 2020. Vol. 20, N 1. P. 401. doi: 10.1186/s12884-020-03077-6

[7] Garrison A. Screening, diagnosis, and management of gestational diabetes mellitus. Am Fam Physician. 2015;91(7):460–467.

[8] Garrison A. Screening, diagnosis, and management of gestational diabetes mellitus // Am Fam Physician. 2015. Vol. 91, N 7. P. 460–467.

[9] Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19(3342). doi: 10.3390/ijms19113342

[10] Plows J.F., Stanley J.L., Baker P.N., Reynolds C.M., Vickers M.H. The pathophysiology of gestational diabetes mellitus // Int J Mol Sci. 2018. Vol. 19, N 3342. doi: 10.3390/ijms19113342

[11] Mack LR, Tomich PG. Gestational diabetes: diagnosis, classification, and clinical care. Obstet Gynecol Clin North Am. 2017;44(2):207–217. doi: 10.1016/j.ogc.2017.02.002

[12] Mack L.R., Tomich P.G. Gestational diabetes: diagnosis, classification, and clinical care // Obstet Gynecol Clin North Am. 2017. Vol. 44, N 2. P. 207–217. doi: 10.1016/j.ogc.2017.02.002

[13] McIntyre HD, Catalano P, Zhang C, et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. doi: 10.1038/s41572-019-0098-8

[14] McIntyre H.D., Catalano P., Zhang C., et al. Gestational diabetes mellitus // Nat Rev Dis Primers. 2019. Vol. 5, N 1. P. 47. doi: 10.1038/s41572-019-0098-8

[15] Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134–1138. doi: 10.1056/NEJM200010193431601

[16] Langer O., Conway D.L., Berkus M.D., Xenakis E.M., Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus // N Engl J Med. 2000. Vol. 343, N 16. P. 1134–1138. doi: 10.1056/NEJM200010193431601

[17] Romero R, Erez O, Huttemann M, et al. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol. 2017;217(3):282–302. doi: 10.1016/j.ajog.2017.06.003

[18] Romero R., Erez O., Huttemann M., et al. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity // Am J Obstet Gynecol. 2017. Vol. 217, N 3. P. 282–302. doi: 10.1016/j.ajog.2017.06.003

[19] Zhao L, Sheng X, Zhou Sh, et al. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br J Clin Pharmacol. 2015;80(5):1224–1234. doi: 10.1111/bcp.12672

[20] Zhao L., Sheng X., Zhou Sh., et al. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis // Br J Clin Pharmacol. 2015. Vol. 80, N 5. P. 1224–1234. doi: 10.1111/bcp.12672

[21] Nachum Z, Zafran N, Salim R, et al. Glyburide versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A randomized controlled study. Diabetes Care. 2017;40(3):332–337. doi: 10.2337/dc16-2307

[22] Nachum Z., Zafran N., Salim R., et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A randomized controlled study // Diabetes Care. 2017. Vol. 40, N 3. P. 332–337. doi: 10.2337/dc16-2307

[23] George A, Mathews JE, Sam D, et al. Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide ― a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2015;55(1):47–52. doi: 10.1111/ajo.12276

[24] George A., Mathews J.E., Sam D., et al. Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide ― a randomised controlled trial // Aust N Z J Obstet Gynaecol. 2015. Vol. 55, N 1. P. 47–52. doi: 10.1111/ajo.12276

[25] Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol. 2010;115(1):55–59. doi: 10.1097/AOG.0b013e3181c52132

[26] Moore L.E., Clokey D., Rappaport V.J., Curet L.B. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial // Obstet Gynecol. 2010. Vol. 115, N 1. P. 55–59. doi: 10.1097/AOG.0b013e3181c52132

[27] Pellonperä O, Rönnemaa T, Ekblad U, Vahlberg T, Tertti K. The effects of metformin treatment of gestational diabetes on maternal weight and glucose tolerance postpartum ― a prospective follow-up study. Acta Obstet Gynecol Scand. 2016;95(1):79–87. doi: 10.1111/aogs.12788

[28] Pellonperä O., Rönnemaa T., Ekblad U., Vahlberg T., Tertti K. The effects of metformin treatment of gestational diabetes on maternal weight and glucose tolerance postpartum ― a prospective follow-up study //Acta Obstet Gynecol Scand. 2016. Vol. 95, N 1. P. 79–87. doi: 10.1111/aogs.12788

[29] Silva JC, Fachin DRRN, Coral ML, Bertini AM. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus // J Perinat Med. 2012. Vol. 40, N 3. P. 225–228. doi: 10.1515/jpm-2011-0175

[30] Silva J.C., Fachin D.R.R.N., Coral M.L., Bertini A.M. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus // J Perinat Med. 2012. Vol. 40, N 3. P. 225–228. doi: 10.1515/jpm-2011-0175

[31] Bouchghoul H, Alvarez J-C, Verstuyft C, Bouyer J, Senat M-V. Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk. PloS One. 2020;15(5):e0232002. doi: 10.1371/journal.pone.0232002

[32] Bouchghoul H., Alvarez J.-C., Verstuyft C., Bouyer J., Senat M.-V. Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk // PloS One. 2020. Vol. 15, N 5. P. e0232002. doi: 10.1371/journal.pone.0232002

[33] Sénat M-V, Affres H, Letourneau A, et al. Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A randomized clinical trial. JAMA. 2018;319(17):1773–1780. doi: 10.1001/jama.2018.4072

[34] Sénat M.-V., Affres H., Letourneau A., et al. Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A randomized clinical trial // JAMA. 2018. Vol. 319, N 17. P. 1773–1780. doi: 10.1001/jama.2018.4072

[35] Hebert MF, Ma X, Naraharisetti SB, et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther. 2009;85(6):607–614. doi: 10.1038/clpt.2009.5

[36] Hebert M.F., Ma X., Naraharisetti S.B., et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice // Clin Pharmacol Ther. 2009. Vol. 85, N 6. P. 607–614. doi: 10.1038/clpt.2009.5

[37] Shuster DL, Shireman LM, Ma X, et al. Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin combination therapy in the treatment of gestational diabetes mellitus. Clin Pharmacol Ther. 2020;107(6):1362–1372. doi: 10.1002/cpt.1749

[38] Shuster D.L., Shireman L.M., Ma X., et al. Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin combination therapy in the treatment of gestational diabetes mellitus // Clin Pharmacol Ther. 2020. Vol. 107, N 6. P. 1362–1372. doi: 10.1002/cpt.1749

[39] Reynolds RM, Denison FC, Juszczak E, et al. Glibenclamide and metfoRmin versus stAndard Care in gEstational diabeteS (GRACES): a feasibility open label randomised trial. BMC Pregnancy Childbirth. 2017;17(1):316. doi: 10.1186/s12884-017-1505-3

[40] Reynolds R.M., Denison F.C., Juszczak E., et al. Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial // BMC Pregnancy Childbirth. 2017. Vol. 17, N 1. P. 316. doi: 10.1186/s12884-017-1505-3

RIGHTS & PERMISSIONS

Eco-Vector